FINEOS (ASX:FCL) share price jumps 15% on solid FY21 result

Here's how FINEOS fared in its FY21 results…

| More on:
Happy child jumping for joy.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The FINEOS Corporation Holdings PLC (ASX: FCL) share price is gaining upwards momentum today.

Investors are buying shares in the insurance software company with ferocity on Thursday after it released its full-year results for FY21.

At the time of writing, FINEOS shares are up 16% to $4.27. As a result, the software company is again trading around levels witnessed in April this year.

FINEOS share price shines on top line gain

  • Revenue up 23.3% to €108.3 million (AUD$175.6 million)
  • Annual recurring revenue reached €45.7 million at 30 June 2021
  • Gross profit of €72 million representing an increase of 23% from FY20
  • Proforma earnings before interest, tax, depreciation, and amortisation (EBITDA) down 49.6% to €7.9 million
  • Net Loss after tax widened from €227,183 to €12.485 million

What happened in FY21 for FINEOS

The market is certainly exhibiting excitement for the FINEOS share price following its results today. In fact, trading volume for the day so far is roughly two and a half times its monthly average.

According to its release, the software company achieved total revenue of €108.3 million in the financial year. This represents an increase of 23.3% on FY20. Likewise, subscription revenue surged 48.6% to €40.1 million. Such an increase bodes well for the company, as it grows its portion of revenue that is recurring.

It wasn't by chance that FINEOS managed to up the ante with respect to revenue in FY21. Rather, it was the expansion of its life, accident, and health core systems — reaching over 60 carriers. Intentionally, the United States now accounts for 73% of total revenue, rising from 59% in the previous reporting period.

Furthermore, the successful acquisitions and integrations of Limelight Health and Spraoi during the year contributed to the strong growth. Specifically, Limelight Health added €9.2 million and Spraoi contributed €0.4 million.

Much of this reported growth was from cross-selling and up-selling to FINEOS' existing customer base. Indicating that the company is not purely 'buying revenue' through acquisition, FINEOS reported organic growth of 12.5%.

Another positive for shareholders, the company appears to have marginally de-risked its client concentration. In FY20, ~74% of total revenue was comprised of the top 10 clients. Whereas, in its latest full-year result, this figure has been reduced to 65%.

Finally, losses widened due to acquisition costs — in addition to increased spend on research and development (R&D). Though, this doesn't appear to be weighing on the FINEOS share price today.

What did management say?

Commenting on the result, FINEOS Chief Executive Officer Michael Kelly said:

FINEOS' growth journey continued into 2021 as we grew revenue, clients, headcount and product offering. We're now positioned as the number one player for group employee benefits in the North American market, measured by revenue, by number of clients and by the end-to-end "quote to claim" product that we provide.

Our primary focus was and continues to be increasing our subsription revenues as we grow FINEOS into the global market leading software-as-a-service platform for life, accident, and health insurance.

Additionally, regarding the company's acquisitions during the period, Mr Kelly said:

We are pleased with the revenue growth, specifically our higher margin subscription revenue which grew
by 48.6% to €40.1 million. Within this, organic growth was a strong 32.4% with the balance from the two acquisitions we made during the year (Limelight Health and Spraoi). This year's revenue growth was
attributable to successful client implementations, cloud upgrades and add-on cross sales.

What's next for FINEOS ?

Heading into FY22, the company is guiding for €125 million to €130 million in revenue. Positively, subscription revenue is expected to increase approximately 30%.

FINEOS management mentioned that these growth projections are supported by a robust pipeline of significant cross-sell and up-sell opportunities with existing clients. These are in addition to some fresh client opportunities also being presented.

Meanwhile, the R&D costs aren't expected to decrease for the next year. Instead, R&D expenses will continue as the company integrates its acquisitions and works more on product development.

Additionally, the company will be focused on further cloud upgrades in FY22. In particular, several migrations are slated across the United States and ANZ regions during the year.

FINEOS share price snapshot

Although the FINEOS share price is gleaming green today, the past year does not mimic the same performance. Over the past 12 months, the FINEOS share price has fallen 21.5%. For comparison, the S&P/ASX 200 Index (ASX: XJO) has gained 22.3%.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended FINEOS Corporation Holdings plc. The Motley Fool Australia has recommended FINEOS Corporation Holdings plc. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Bank Shares

Best ASX stock to buy right now: Macquarie vs. Westpac

What do brokers think about these two ASX bank stocks?

Read more »

A group of businesspeople clapping.
Opinions

My prediction for the best-performing ASX sectors in 2025

Here’s where I think the outperformers will come from.

Read more »

a woman holds a facebook like thumbs up sign high above her head. She has a very happy smile on her face.
Broker Notes

Bell Potter names more of the best ASX 200 shares to buy in 2025

Let's see why these shares have been given a big thumbs up by the broker ahead of the new year.

Read more »

A family of four wearing Santa hats open presents on the beach next to a Christmas tree.
Opinions

Top ASX shares to buy before Christmas

Here are some guilt-free purchases that you can snag without battling a crowd this Christmas.

Read more »

A man wearing a red jacket and mountain hiking clothes stands at the top of a mountain peak and looks out over countless mountain ranges.
Share Gainers

Here are the top 10 ASX 200 shares today

ASX shares had a rough end to the trading week this Friday.

Read more »

Business people standing at a mine site smiling.
Resources Shares

5 ASX mining shares to buy now: experts

Today is a grey day for ASX mining stocks but brokers say the future looks bright.

Read more »

Businessman studying a high technology holographic stock market chart.
Opinions

Where will the ASX 200 be this time next year?

Morgan Stanley has delivered its forecast for the Australian share market in 2025.

Read more »

Three exuberant runners dash towards the camera. One raises her arms in triumph; another jumps in the air with arms raised. The third runner gives a satisfied smile.
Share Gainers

3 ASX 200 stocks charging higher this week even as the market sinks

These three ASX 200 stocks leapt higher this week despite the sinking market.

Read more »